<DOC>
	<DOC>NCT01915511</DOC>
	<brief_summary>This registry will collect data on the strategies used to achieve a diagnosis of Idiopathic Pulmonary Fibrosis (IPF) and the treatment and management efforts applied throughout study follow-up, clinical outcome events and patient reported outcome data. Blood samples will be collected periodically throughout the study for use in future research efforts.</brief_summary>
	<brief_title>Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<criteria>Willing and able to provide informed consent Established a new diagnosis of IPF by the enrolling subspecialty center (as defined by ATS/ERS/JRS/ALAT criteria) Age &gt; 40 years or older Previously diagnosed with IPF by the enrolling subspecialty center. Only participants newly diagnosed with IPF will be included. Malignancy, treated or untreated, other than skin cancer, within the past 5 years Currently listed for lung transplantation at the time of enrollment Currently enrolled in a randomized clinical trial at the time of enrollment in this registry</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Idiopathic pulmonary fibrosis</keyword>
	<keyword>Pulmonary fibrosis</keyword>
	<keyword>IPF</keyword>
	<keyword>Registry</keyword>
	<keyword>1199.174</keyword>
</DOC>